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ARTICLE
Using Genomic Inbreeding Coefficient Estimates for
Homozygosity Mapping of Rare Recessive Traits: Application
to Taybi-Linder Syndrome
Anne-Louise Leutenegger, Audrey Labalme, Emmanuelle Ge´nin, Annick Toutain, Elisabeth Steichen,
Franc¸oise Clerget-Darpoux, and Patrick Edery
The use of inbred patients whose exact genealogy may not be available is of primary interest in mapping genes involved
in rare recessive diseases. We show here that this can be achieved by estimating inbreeding coefficients from the patients’
genomic information and using these estimates to perform homozygosity mapping. We show the interest of the approach
by mapping a gene for Taybi-Linder syndrome to chromosome 2q, with the use of a key patient with no genealogical
information.
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Affected offspring from consanguineous marriages may be
of particular interest in mapping genes involved in reces-
sive diseases. The disease locus is, indeed, likely to be
found in a region where affected individuals have received
twice the same ancestral allele (identical by descent [IBD]).
In such a region, the alleles at polymorphic loci surround-
ing the disease locus are likely to be also IBD. The patient
is said to be autozygous in such a region.
Lander and Botstein1 proposed a method, referred to as
“homozygosity mapping,” that consists of searching for a
region of the genome that is autozygous in inbred indi-
viduals affected by a given disease. They showed that, to
quantify the evidence of linkage provided by such a re-
gion, a LOD score could be computed for the marker ob-
servations by comparing the likelihood of being at the
disease locus with the likelihood of being at a random
point on the genome. Calculation of the latter likelihood
requires that, for each affected inbred individual, the
chance of having two IBD alleles at a locus randomly sam-
pled on the individual’s genome is known. By definition,2,3
this value is the individual’s inbreeding coefficient (F).
Efficient algorithms4–7 based on the known genealogy
have been previously developed to compute F.
However, information on genealogy may not be accu-
rate or may even be lacking, especially for populations in
which marriages between relatives are very frequent, mak-
ing relationships very complex. Miano et al.8 reported
some pitfalls in homozygosity mapping. One of them was
potential LOD score inflation and hence potential increase
in false linkage evidence because of underestimation of
the extent of inbreeding in the affected individual or,
equivalently, of the extent of kinship between the parents
of a patient. More generally in linkage analysis, under-
estimation of the parental relationships may lead to an
increase in type I error.9
Here, we propose to estimate F from each individual’s
genomic information (by FEstim) as presented by Leute-
negger et al.10 and to use this genomic F to control for
parental relationships in the LOD score computation.
Hence, to perform linkage analysis when parental rela-
tionships are poorly known, we introduce a new homo-
zygosity mapping statistic, FLOD. This statistic allows in-
vestigators to include inbred patients in homozygos-
ity mapping without having any knowledge of their
genealogy.
We show the advantage of FLOD over the usual ho-
mozygosity mapping LOD score (HMLOD) by mapping
the first locus for an autosomal recessive disease, Taybi-
Linder syndrome, with the use of a key patient without
any genealogical information.
Methods
Estimation of the Genomic Inbreeding Coefficient by FEstim
We have proposed a new method, FEstim, to estimate the in-
breeding coefficient F of an individual by use of the individual’s
genomic data.10 Our method does not require any knowledge of
the parental relationships. Instead, it uses only information on
genotypes at random markers throughout the individual’s ge-
nome, which allows an estimation of the proportion of the ge-
nome that is autozygous. The observed marker genotypes are
modeled by a hidden Markov chain that depends on F and on
the rate of change of IBD status per cM. These are both estimated
by maximum likelihood, with the intermarker genetic distances
and marker-allele frequencies specified. It is worth noting that
the reliability of our estimator depends on the informativity at
each point of the genome—that is, on the density and hetero-
zygosity rate of the markers.
FEstim gives more-specific information about an individual’s
genome than the genealogy does, because it better reflects the
true proportion of the individual’s genome that is autozygous.
Indeed, the genealogical F is the expected value of the genomic
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F. Since the genome of an individual is of finite size and only
represents a small gene sampling, a large variance around this
expected value may be observed. Thus, the use of an individual’s
genealogy to estimate the chance of having two IBD alleles at
any random point on the genome may give estimates that are
very far from what is actually happening on the genome. For
offspring of first cousins, for instance, the probability of sampling
an autozygous marker from their genome may be as low as 3%
and as high as 12% when its expected value from the genealogy
is 6%.10
New Homozygosity Mapping Statistic FLOD
We propose to incorporate this genomic F, estimated for each
affected inbred individual, into the LOD score statistic, instead
of F estimated from the genealogy. For a given affected inbred
individual, we define FLOD at marker k as
P(X p 1 dY) qP(X p 0 dY)k klog ,10 f q(1 f )
where f is the genomic estimate of F, q is the disease-allele fre-
quency, Xk is the IBD status at marker k (1 for IBD; 0 for non
IBD), and Y is the observed genotypes at all markers along the
individual’s genome. The LOD score statistic FLOD is computed
using a multipoint method. More details can be found in the
work of Leutenegger.11
For a sample of independent, affected inbred individuals, the
FLOD value for the sample is the sum of each individual FLOD.
This statistic enables us to include in a linkage analysis any
affected individuals, without requiring any genealogical
information.
When siblings of a patient are available for study, FEstim es-
timates are obtained for all of them, and the median value for
the whole sibship can then be used to represent the parental
kinship. The FEstim estimation and FLOD computation have
been implemented in the FEstim software, which is available on
request (leutenegger@vjf.inserm.fr).
Taybi-Linder Syndrome Data
Taybi-Linder syndrome, or microcephalic osteodysplastic pri-
mordial dwarfism (MOPD) type I/III (MIM 210710), is a very rare
autosomal recessive condition. It is characterized by intrauterine
growth retardation, low birth weight, dwarfism, bone dysplasia,
facial anomalies, microcephaly, and malformations of the brain.12
Fewer than 30 patients have been described to date, many of
whom died within the 1st year of life because of infectious
disease.13
Here, we study a sample of four inbred patients, including two
siblings (patients 1 and 2). The patients originated from the Med-
iterranean region: Algeria, Turkey, and Morocco. Clinical reports
on the four patients are given elsewhere—for patients 1–3, the
manuscript is in preparation, and patient 4 was reported as case
4 by Sigaudy et al.13 (the other patients described in that article
died within the first few mo of life; DNA from only patient 4 was
available for the present study). In all cases, inbreeding was pre-
sent but not well documented. For the affected siblings and pa-
tient 3, we had information that the parents were first cousins
and that additional relationships were likely. For patient 4, there
was no genealogical information at all. Additional members of
the nuclear family were available for patients 1 and 2 (three un-
affected siblings and their parents) and for patient 3 (her parents).
On the other hand, we had no relatives of patient 4. In total,
blood samples from 11 individuals were collected. Participants
gave informed consent. DNA was extracted from blood lympho-
cytes by use of standard procedures. A high-density genomewide
scan was performed through deCODE services with the use of a
1,000-marker fluorescent-labeled microsatellite screening set that
covered the whole genome with an average density of 3.7 cM,
where genetic locations were based on the deCODE map.14 The
map used here allows us to get very accurate estimates of the
genomic inbreeding coefficient F with FEstim. Indeed, with the
specific map characteristics, we have, as in the work of Leute-
negger et al.,10 a high correlation of 0.9 between the estimated F
and the true proportion of genome IBD for offspring of first
cousins.
First, we estimated the genomic inbreeding coefficient of all
patients and their available siblings, using FEstim. We then com-
puted FLOD for the whole sample with these estimated F values.
Finally, we computed HMLOD, assuming a first-cousin relation-
ship for the parents of patients 1, 2, and 3 while excluding patient
4 because the calculation could not be done using a standard
computer package, such as Allegro.15 For all LOD score compu-
tations, we used a fully penetrant autosomal recessive model and
a disease-allele frequency of 0.00001. To check the sensitivity of
our results to the disease-allele frequency, we also performed the
analysis with a frequency of 0.0001. The LOD score values were
identical up to the second decimal place (not shown).
Results
FEstim inbreeding coefficient estimates and 95% CIs are
shown in figure 1. All inbreeding-coefficient estimates of
patients were significantly different from zero. In partic-
ular, patient 4 had an estimated F of 0.06, which showed
that the parents are, in fact, closely related. This patient
is thus informative for linkage, whereas previously the
patient could not be used in any linkage analysis. For sib-
lings 1 and 2, who have additional siblings available, we
observed a large variability of the FEstim estimates for the
sibship, from 0.04 to 0.13. The estimate for patient 3 in-
dicates the probable existence of remote consanguinity
besides the first-cousin relationship of her parents. Her F
is estimated to be 0.13, which is significantly ( )P ! .025
higher than 0.06, the expected inbreeding coefficient for
first-cousin offspring.
First, we used these FEstim estimates to compute the
multipoint FLOD statistic on the entire sample of the pa-
tients and their available relatives. We obtained a maxi-
mum FLOD of 3.28 at the D2S347 marker. Moreover, an
FLOD value 13 was also reached at D2S2271, the marker
adjacent to D2S347. No other chromosomal region gave
combined LOD scores 12. A study of the affected individ-
uals’ haplotypes on the chromosome 2q region showed
meiotic recombinations between centromeric markers
D2S2254 and D2S347 for patient 3 and between telomeric
markers D2S2271 and D2S2215 for patients 1 and 2, thus
restricting the autozygous candidate region to an ∼13-cM
interval flanked by D2S2254 and D2S2215 on chromo-
some 2q14.2-2q14.3 (table 1).
To compare our results with the usual homozygosity
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Figure 1. FEstim-estimated inbreeding coefficient (F), SE, and 95% CI for the patients with Taybi-Linder syndrome and siblings. The
median F value for each sibship and the reported parental relationships are also specified. The 95% CIs were computed as F 1.96
SE.
Table 1. Haplotypic Analysis Showing Candidate Region for the Taybi-Linder Syndrome Locus
on Chromosome 2q14
Algeria Turkey
Location
(cM) Marker Parents
Unaffected
Siblings Patient 1 Patient 2 Parents Patient 3
Morocco
Patient 4
132.2 D2S2254 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 12 2 12 9 9
138.1 D2S347 1 5 1 8 1 5 8 5 8 1 1 1 1 1 1 9 6 1 1 1 1 1
143.6 D2S2271 3 3 3 4 3 3 4 3 4 3 3 3 3 3 2 6 1 2 2 2 3 3
145.4 D2S2215 5 9 9 3 9 9 3 9 3 5 9 5 9 5 4 7 7 4 4 4 10 10
NOTE.—Patients’ haplotypes defining the candidate region are shaded.
mapping statistic, we computed HMLOD for patients 1
and 2 (the siblings), patient 3, and their available relatives,
assuming a first-cousin relationship for the parents. We
did not find evidence of linkage in any part of the genome,
but we had some suggestive results, since the combined
HMLOD exceeded 2 in two chromosomal regions. We ob-
tained LOD score values of 2.62 on chromosome 2q at
D2S347 and of 2.19 on chromosome 7q at D7S514. Thus,
no clear-cut linkage could be established by including only
these three patients and their available relatives in the
linkage study. As can be seen in figure 2, because of our
FLOD statistic and the inclusion of patient 4, it was pos-
sible, first, to exclude the 7q region, which had an FLOD
value of 1.25, and, second, to get a LOD score 13 in the
2q region.
Discussion
We have mapped the first Taybi-Linder syndrome locus to
chromosome 2q, using our genomically controlled ho-
mozygosity mapping method. It allowed us to include in
the analysis a key patient with no available genealogy. It
is also interesting to note that this patient (patient 4), with
an estimated genomic F of 0.06, is actually more infor-
mative for linkage than patient 3, who had an estimated
genomic F of 0.13.
It is worth noting that, for patient 3, the LOD score
values obtained with HMLOD under the assumption that
her parents are first cousins were inflated. This statistic
reached 1.2 on chromosome 2q; however, with her actual
inbreeding level of 0.13, the LOD score should be reduced
by log10(2), thus reaching only 0.9, the observed FLOD
value on chromosome 2q.
Our proposed solution to incorporate the genomic F of
each affected inbred individual, instead of the expected F
from the genealogy, into the LOD score statistic should
make it easier to map autosomal recessive traits. The FLOD
statistic has the great advantage of taking into account the
actual inbreeding of individuals and its variability while
allowing researchers to study a sample of patients without
requiring any genealogical information. As for any linkage
study, however, it does require a very informative marker
map. This was the case here, in which we used a map with
an average intermarker distance of 3.7 cM and an average
heterozygosity rate of 0.75. A more standard 10-cM mi-
crosatellite map would yield less precise F estimates.
The approach proposed here is especially well suited to
studying patients from populations with a long tradition
of marriages between close relatives. For the case of pop-
ulations with lower levels of inbreeding, such as founder
populations, we are working on a typing strategy that
would allow this sparse inbreeding to be correctly cap-
tured. Indeed, in that case, one needs a high informativity
at each point of the genome, which depends on both
marker informativity and density. This will likely require
mixing SNP and microsatellite markers. However, when
Figure 2. LOD score plots of FLOD (black lines) and HMLOD (dashed gray lines) over the whole genome (A), chromosome 2q (B), and
chromosome 7q (C) for the Taybi-Linder syndrome data. On the genomewide plot (A), the chromosome numbers are written at the top.
B and C, FLOD123 (solid gray lines) represents FLOD computed for patients 1, 2, and 3 and their available relatives only (not patient
4). The solid horizontal lines represent a LOD score of 3.
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very dense marker maps are used, it is important to take
into account the linkage disequilibrium that may be pre-
sent between marker alleles. Finally, we currently are re-
fining the disease locus interval and are undertaking a
candidate-gene strategy with the aim of identifying the
Taybi-Linder syndrome–causing gene itself.
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